FERUMOXYTOL
| Brand name | FERABRIGHT |
|---|---|
| Active ingredient | FERUMOXYTOL |
| Strength | EQ 300MG IRON/10ML (EQ 30MG IRON/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | October 2025 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| NP | October 2028 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.